Peptide ChooserPeptides for energy and aging, compared with the evidence.
Nothing on this page is FDA approved. Epitalon and MOTS-c were reviewed by an FDA advisory committee in July 2026 for pharmacy compounding, and the FDA proposed keeping them off the list. NAD+ is not a peptide at all; clinics sell it as shots and drips without approval. We show prices and checks for the research-use products and do not link to the shops.
Compare the options
Is it legal today?For "anti-aging" and more energy: what is sold, what the evidence says, and what is not even a peptide.
- Prices at 10 shops
EpitalonNot approved
A four-amino-acid peptide sold as an "anti-aging" shot; human evidence is thin and old. Reviewed by the FDA in July 2026; proposed exclusion. 6
Not approved.
Research-use shops.
- Prices at 10 shops
MOTS-cNot approved
A "mitochondrial" peptide sold for energy; animal studies only. Same July 2026 review. 6
Not approved.
Research-use shops.
- Prices at 10 shops
NAD+ injectionsPharmacy-madeNot a peptide
Not a peptide: a vitamin-B3-derived molecule sold by clinics as shots or drips for energy.
Not FDA approved.
Clinics and compounding pharmacies.
Every option, side by side
3 options, each with its FDA status and how you get it.
| Option | FDA status | How you get it |
|---|---|---|
| EpitalonA four-amino-acid peptide sold as an "anti-aging" shot; human evidence is thin and old. Reviewed by the FDA in July 2026; proposed exclusion. 6 | Not approvedNot approved. | Research-use shops. |
| MOTS-cA "mitochondrial" peptide sold for energy; animal studies only. Same July 2026 review. 6 | Not approvedNot approved. | Research-use shops. |
| NAD+ injectionsNot a peptideNot a peptide: a vitamin-B3-derived molecule sold by clinics as shots or drips for energy. | Pharmacy-madeNot FDA approved. | Clinics and compounding pharmacies. |
Is it legal today?
FDA status of the peptides on this page, each with its source. Checked 19 Oct 2026.
| Peptide | Status | What that means |
|---|---|---|
| Epitalon | Not approved | its nomination for pharmacy compounding was withdrawn FDA source, 19 Oct 2026. Same July 2026 review; FDA proposed not to allow it. 6 |
| MOTS-c | Not approved | its nomination for pharmacy compounding was withdrawn FDA source, 19 Oct 2026. Same July 2026 review; FDA proposed not to allow it. 6 |
| NAD+ | Pharmacy-made | pharmacies may compound it while the FDA reviews it; no approved product FDA source, 19 Oct 2026 |
Approved means the FDA approved a product containing it for a stated use. Not approved means no approved product exists; buying it for yourself is not a crime in the US, but nobody has checked what is in the vial.
Compare other goals
Sources
- FDA Briefing Document, Pharmacy Compounding Advisory Committee meeting, 23 and 24 Jul 2026 (BPC-157, TB-500, MOTS-c, epitalon): https://www.fda.gov/media/193342/download